News Releases 2000

12-15-2000
MDS Reports Record 2000 Results
12-06-2000
MDS Provides New Genetic Test for Colon and Uterine Cancer
10-05-2000
Canadian technology leader celebrates record growth and success
09-28-2000
Xenogen Corporation Announces Acquisition of DNX Transgenic Sciences (DNX)
09-27-2000
MDS Inc. Announces The Formation Of MDS Pharma Services Third Largest CRO In The World
09-27-2000
MDS Nordion And NEXUS AG Collaborate On Oncology Information Management
09-21-2000
MDS Inc. Closes $198 Million Equity Offering
09-14-2000
MDS Reports Third Quarter Earnings
09-14-2000
MDS Inc. Announces Cash Dividend and Stock Dividend
09-06-2000
MDS Announces $153 Million Offering
08-28-2000
First MDS Nordion treatment using IMRT helps cancer patient
08-17-2000
MDS Nordion and Canada's National Research Council Share Technology
07-21-2000
MDS Nordion Supports FDA Ruling to Fight Salmonella in Eggs
06-19-2000
MDS Inc. Normal Course Issuer Bid
06-15-2000
MDS Reports Second Quarter Earnings
06-08-2000
MDS Invests US$15 Million Strategic Investment in INPHACT, a Leading e-Imaging Company
06-01-2000
MDS Capital Corp. Participates In Forming eHealthPark
05-01-2000
MDS Pharma Services Unveils State-of-the-Art Laboratory
04-25-2000
MDS Rings Opening Bell at NYSE
04-07-2000
Phoenix Shareholders Accept MDS Offer to Purchase MDS Lists on NYSE
04-07-2000
MDS's Acquisition of Phoenix Completed and Sector Leader Named
03-31-2000
MDS / Phoenix Acquisition Receives CCB No-Action Letter
03-27-2000
MDS Extends Offer to Phoenix Shareholders
03-23-2000
MDS Inc. to List on NYSE
03-16-2000
Paladin and MDS Announce Availability of NMP22(R) Test for Bladder Cancer in MDS Labs
03-13-2000
Circular Notification - MDS Offer to Phoenix Shareholders
03-09-2000
MDS Acquires INH Technologies Inc.
03-09-2000
MDS Brings World-Renowned Genetic Test To Canadian Women
03-06-2000
MDS Announces Stock Symbol Change
03-03-2000
MDS Inc. Shareholders Approve Share Restructuring
03-02-2000
MDS Reports Strong First Quarter
02-25-2000
Physicians And Patients Collaborate On New Diagnostic Tests
02-24-2000
MDS Inc. Offers to Purchase Phoenix International Life Sciences Inc.